Skip to main content
Top
Published in: Current Hypertension Reports 12/2018

01-12-2018 | Invited Commentary

The Mediterranean Diet: Lost in Translation

Authors: Louis Kuritzky, Scott Lang

Published in: Current Hypertension Reports | Issue 12/2018

Login to get access

Abstract

Purpose of Review

Despite substantive evidence documenting the efficacy of the Mediterranean diet to reduce cardiovascular events, underutilization is common. An overview of the data set supporting the role of the Mediterranean diet as confirmed in both observational and interventional trials should stimulate greater clinician interest in the diet. Additionally, the availability of patient-friendly tools that enable prompt and easy adoption of the Mediterranean diet, that are able to be used by clinicians who claim no special expertise in diet knowledge, should simplify the path to successful dietary change.

Recent Findings

A large recently published (2018) prospective study of the Mediterranean diet for primary prevention of cardiovascular events confirmed that compared to control, Mediterranean diet is associated with reduced risk for cardiovascular events in high risk patients.

Summary

Of the tools available to clinicians that might reduce cardiovascular risk, dietary intervention is the one least utilized. The evidence supports the value of dietary intervention with the Mediterranean diet, and methods to effectively employ it within the confines of typical office practice are readily at hand.
Literature
2.
go back to reference Kezerashvili A, Marzo K, de Leon J. Beta blocker use after acute myocardial infarction in the patient with normal systolic function: when is it “ok” to discontinue? Curr Cardiol Rev. 2012;8:77–84.CrossRef Kezerashvili A, Marzo K, de Leon J. Beta blocker use after acute myocardial infarction in the patient with normal systolic function: when is it “ok” to discontinue? Curr Cardiol Rev. 2012;8:77–84.CrossRef
3.
go back to reference Stenestrand U, et al. Early statin treatment following acute myocardial infarction and 1-year survival. JAMA. 2001;285:430–6.CrossRef Stenestrand U, et al. Early statin treatment following acute myocardial infarction and 1-year survival. JAMA. 2001;285:430–6.CrossRef
4.
go back to reference Wilson K, Gibson N, Willan A, Cook D. Effect of smoking cessation on mortality after myocardial infarction. Arch Int Med. 2000;160:939–44.CrossRef Wilson K, Gibson N, Willan A, Cook D. Effect of smoking cessation on mortality after myocardial infarction. Arch Int Med. 2000;160:939–44.CrossRef
5.
go back to reference De Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N, et al. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction. Circulation. 1999;99:779–85.CrossRef De Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N, et al. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction. Circulation. 1999;99:779–85.CrossRef
6.
go back to reference Estruch R, Ros E, Salas-Saqlvado J, Covas JI, Corelia D, Aros F, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;38(14):1279–90.CrossRef Estruch R, Ros E, Salas-Saqlvado J, Covas JI, Corelia D, Aros F, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;38(14):1279–90.CrossRef
7.
go back to reference Estruch R, Ros E, Salas-Salvado J, Covas M-I, Corella D, Aros F, et al. Primary Prevention of cardiovascular disease with a mediterranean diet supplemented with extra-virgin olive oil or nuts. N Engl J Med. 2018;378(25):e34(1)–e34(14).CrossRef Estruch R, Ros E, Salas-Salvado J, Covas M-I, Corella D, Aros F, et al. Primary Prevention of cardiovascular disease with a mediterranean diet supplemented with extra-virgin olive oil or nuts. N Engl J Med. 2018;378(25):e34(1)–e34(14).CrossRef
8.
go back to reference Mitrou PN, Kipnis V, Thiebaut ACM, Reedy J, Subar AF, Wifralt E, et al. Mediterranean dietary pattern and prediction of all-cause mortality in a US population. Arch Intern Med. 2007;167(22):2461–8.CrossRef Mitrou PN, Kipnis V, Thiebaut ACM, Reedy J, Subar AF, Wifralt E, et al. Mediterranean dietary pattern and prediction of all-cause mortality in a US population. Arch Intern Med. 2007;167(22):2461–8.CrossRef
9.
go back to reference Valis-Pedret C, Sala-Vila A, Serra-Mir M, Corella D, de la Torre R, Martinez-Gonzalez MG, et al. Mediterranean diet and age related cognitive decline. JAMA Intern Med. 2015;175(7):1094–103.CrossRef Valis-Pedret C, Sala-Vila A, Serra-Mir M, Corella D, de la Torre R, Martinez-Gonzalez MG, et al. Mediterranean diet and age related cognitive decline. JAMA Intern Med. 2015;175(7):1094–103.CrossRef
10.
go back to reference Mancini JG, Filion KB, Atallah R, Eisenberg MJ. Systematic review of the Mediterranean diet for long-term weight loss. Am J Med. 2016;129:407–15.CrossRef Mancini JG, Filion KB, Atallah R, Eisenberg MJ. Systematic review of the Mediterranean diet for long-term weight loss. Am J Med. 2016;129:407–15.CrossRef
11.
go back to reference Shai I, Schwarzfuchs D, Henkin Y, Shahar DR, Sitkow S, Greenberg I, et al. Weight loss with a low carbohydrate, Mediterranean, or low-fat diet. N Engl J Med. 2008;359:229–41.CrossRef Shai I, Schwarzfuchs D, Henkin Y, Shahar DR, Sitkow S, Greenberg I, et al. Weight loss with a low carbohydrate, Mediterranean, or low-fat diet. N Engl J Med. 2008;359:229–41.CrossRef
12.
go back to reference Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, et al. Effect of a Mediterranean style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome. JAMA. 2004;292:1440–6.CrossRef Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, et al. Effect of a Mediterranean style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome. JAMA. 2004;292:1440–6.CrossRef
Metadata
Title
The Mediterranean Diet: Lost in Translation
Authors
Louis Kuritzky
Scott Lang
Publication date
01-12-2018
Publisher
Springer US
Published in
Current Hypertension Reports / Issue 12/2018
Print ISSN: 1522-6417
Electronic ISSN: 1534-3111
DOI
https://doi.org/10.1007/s11906-018-0904-9

Other articles of this Issue 12/2018

Current Hypertension Reports 12/2018 Go to the issue

Guidelines/Clinical Trials/Meta-Analysis (JB Kostis and W Kostis, Section Editors)

The Relationship Between Psychosocial Status and Hypertensive Condition

Blood Pressure Monitoring and Management (J Cockcroft, Section Editor)

Out of Office Blood Pressure Measurement in Pregnancy and the Postpartum Period

Inflammation and Cardiovascular Diseases (A Kirabo, Section Editor)

Inflammation in Salt-Sensitive Hypertension and Renal Damage

Hypertension and Obesity (E Reisin, Section Editor)

Obesity and Pulmonary Hypertension

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.